Academies’ action plan for germline editing (original) (raw)
- CORRESPONDENCE
- 13 March 2019
By
- Victor J. Dzau
- US National Academy of Medicine, Washington DC, USA.
- Marcia McNutt
- US National Academy of Sciences, Washington DC, USA.
- Venki Ramakrishnan
- Royal Society, London, UK.
We share the concerns raised by Eric Lander and colleagues, who call for a moratorium on clinical uses of heritable human genome editing and emphasize the urgent need for an acceptable international framework.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Nature 567, 175 (2019)
doi: https://doi.org/10.1038/d41586-019-00813-7
Related Articles
-
Adopt a moratorium on heritable genome editing -
Germline gene-editing research needs rules - NIH supports call for moratorium on clinical uses of germline gene editing
-
The CRISPR-baby scandal: what’s next for human gene-editing -
Genome-edited baby claim provokes international outcry - See more letters to the editor
Hybrid refinery process turns plant material into industrially important chemical News & Views 10 JUN 26 
Structural basis for chaperone-guided assembly of RNA-induced silencing complex Article 10 JUN 26 
Lignin to adipic acid in a high-yield chemical and biological redox process Article 10 JUN 26 
Nature Index 2026 Research Leaders rankings: are China’s East Asian neighbours keeping pace with it? Nature Index 10 JUN 26 
Gen Z scepticism towards AI is a wake-up call — universities must take it seriously World View 10 JUN 26 
The Amazon can be saved — with concerted action inside and outside Brazil Editorial 10 JUN 26